专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2009146906A3 OPHTHALMOLOGICAL LASER SYSTEM AND OPERATING METHOD 审中-公开
标题翻译：眼科激光系统和操作方法
公开(公告)号：WO2009146906A3
公开(公告)日：2010-03-11
申请号：PCT/EP2009003980
申请日：2009-06-04
申请人： ZEISS CARL MEDITEC AG , REICH MATTHIAS , GREBNER DIETER , KOCH ANDREAS , LEDERMANN JUERGEN , DICK MANFRED , HANFT MARCO
发明人： REICH MATTHIAS , GREBNER DIETER , KOCH ANDREAS , LEDERMANN JUERGEN , DICK MANFRED , HANFT MARCO
IPC分类号： A61F9/008 , A61B3/117
CPC分类号： A61F9/008 , A61B3/1173 , A61F9/00838 , A61F2009/0087
摘要： It is known for the analysis of the eye lens, particularly in case of presbyopia, to couple the detection optical path into the processing optical path by means of a beam splitter in order to detect the laser light scattered back in the eye lens. Said detection is inaccurate, since the intensity of the light scattered back in the eye lens is very low due to the inherent properties of the eye lens. The invention seeks to enable the detection of the light scattered back in the eye lens at a higher level of accuracy. The use of a polarization beam splitter that selectively decouples the detection light onto the detector such that the same has a polarization direction that differs from the emitted illumination light, enables the detection of the light scattered back in the eye lens at a high level of accuracy, since stray light from reflections at optical components of the light path is suppressed. In the generating of photo disruptions or other incisions, the ray exposure of the retina may be reduced in that the incisions being furthest away from the laser are induced first such that laminar gas inclusions with an exposure time of at least 5 seconds result. In this manner the laser radiation propagated in the direction of the retina in further incisions are scattered and partially reflected such that the influence impinging upon the retina is reduced.
摘要翻译：眼透镜的分析，特别是与老花眼，它是由在加工光束路径中的光束分离器已知为耦合探测光路，以检测在眼睛透镜的反向散射激光。这种检测是不准确的，因为在复眼透镜的反向散射光的强度是很低的，由于晶状体的固有特性。本发明将使反向散射光的在眼睛晶状体的检测精度较高。使用偏振光束分离器中，从而选择性地去耦所述检测器上的检测光，其具有从所述发出的照明光的偏振方向的不同，使得能够以高精确度的眼透镜的光的反向散射的检测中，由于杂散光从反射在光束路径的光学部件抑制，当生成光致破裂或其它切口，可以通过最远处被减少视网膜的辐射暴露从激光切口第一感应，并从而形成固态气体夹杂物的至少5秒的停留时间引起的。其特征在于在视网膜激光辐射的方向的散射传播在其它切口和部分地反射，使得视网膜上的入射角减小通量。

2. 发明专利

DE102008027358A1 未知
公开(公告)号：DE102008027358A1
公开(公告)日：2009-12-10
申请号：DE102008027358
申请日：2008-06-05
申请人： ZEISS CARL MEDITEC AG
发明人： REICH MATTHIAS , GREBNER DIETER , KOCH ANDREAS , LEDERMANN JUERGEN , DICK MANFRED , HANFT MARCO
IPC分类号： A61B3/10 , A61F9/013

3. 发明申请

WO2008141629A1 LAMP SOCKET FOR AN ELECTRIC LAMP 审中-公开
标题翻译： LAMP基地电灯
公开(公告)号：WO2008141629A1
公开(公告)日：2008-11-27
申请号：PCT/DE2008000856
申请日：2008-05-21
申请人： OSRAM GMBH , SCHEMPP & DECKER PRAEZ STEILE , HUBERT STUEKEN GMBH & CO KG , UNIV ERLANGEN NUERNBERG VERTRE , HELBIG PETER , VOGEL ALEXANDER , KOCH ANDREAS , QUADFASEL KARL-HEINZ , EHRENSTEIN GOTTFRIED W , AMESODER SIMON , SZAMEITAT MIKE , SCHOLZ MATTHIAS
发明人： HELBIG PETER , VOGEL ALEXANDER , KOCH ANDREAS , QUADFASEL KARL-HEINZ , EHRENSTEIN GOTTFRIED W , AMESODER SIMON , SZAMEITAT MIKE , SCHOLZ MATTHIAS
IPC分类号： H01R13/405 , H01R43/24
CPC分类号： H01R13/405 , H01R13/03 , H01R13/521 , H01R13/5216 , H01R33/965 , H01R43/005 , H01R43/16 , H01R43/24
摘要： The invention relates to a lamp socket for an electric lamp, preferably a motor vehicle lamp, comprising a plastic socket part and at least one contact tab provided in the plastic socket part for power supply. Between the plastic socket part and the contact tab, at least in sections on the contact tab, a coating is provided for increasing the adhesive strength and tightness between the contact tab and the contact socket part. This can be supported by the application of sealing strips. The result is a plastic socket meeting high sealing requirements with simple production effort.
摘要翻译：这是一个灯座用于电灯，优选机动车辆灯中，提供了其中有一个塑料基体部和在该塑料基体部分接触片用于电流供给提供的至少一个。它由塑料基体部分和所述接触片，用于提高接触片和塑料基体部分之间的粘附性或密封性的涂布部的至少所述接触片之间。这可通过引入密封条的被支持。其结果是一个塑料底座，高密封要求是足够的简单生产的努力。

4. 发明申请

WO2006072329A2 TRANSDERMAL, THERAPEUTIC SYSTEM WITH ACTIVATABLE OVERSATURATION AND CONTROLLED PERMEATION PROMOTION 审中-公开
标题翻译：可激活关于饱和度和控制性渗透增强透皮治疗系统
公开(公告)号：WO2006072329A2
公开(公告)日：2006-07-13
申请号：PCT/EP2005013133
申请日：2005-12-08
申请人： LOHMANN THERAPIE SYST LTS , KOCH ANDREAS
发明人： KOCH ANDREAS
IPC分类号： A61K9/70
CPC分类号： A61K9/7092 , A61K9/7053 , A61K47/10 , A61K47/12 , A61K47/22
摘要： The invention relates to a transdermal therapeutic system (TTS) that is essentially composed of two compartments and that is provided with activatable oversaturation and controlled permeation promotion. The invention more particularly relates to a TTS, wherein an oversaturated active ingredient solution is produced in an active-substance-containing polymer matrix when the system is applied to the skin, caused by the controlled supply of one or several substances promoting permeation of the pharmaceutical active ingredient; the two compartments which make up the inventive transdermal therapeutic system; and the production of said transdermal therapeutic system from the two compartments.
摘要翻译：本发明涉及基本上由两个隔室经皮治疗系统（TTS）与活化的过饱和和受控渗透增强的复合材料。特别地，本发明涉及一种TTS，其中活性化合物在含有药物的聚合物基体的过饱和溶液是在皮肤上产生仅在该系统中，所引起的药剂的一种或多种渗透促进物质受控输送的应用中，两个隔室从其中本发明的透皮治疗系统被组装，以及生产从两个隔间此透皮治疗系统的。

5. 发明申请

WO0041683A3 TRANSDERMAL THERAPEUTIC SYSTEM WITH SELF-ADHESIVE MATRIX, CONTAINING ORGANIC ACID ADDITION SALTS OF MORPHINE- OR MORPHINAN-TYPE ALKALOIDS 审中-公开
标题翻译：用粘合剂MATRIX含生物碱吗啡有机酸盐或透皮治疗系统 MORPHINANTYPS
公开(公告)号：WO0041683A3
公开(公告)日：2001-11-08
申请号：PCT/EP0000198
申请日：2000-01-13
申请人： LOHMANN THERAPIE SYST LTS , KOCH ANDREAS , ADAM BERND , MATUSCH RUDOLF , ASMUSSEN BODO
发明人： KOCH ANDREAS , ADAM BERND , MATUSCH RUDOLF , ASMUSSEN BODO
IPC分类号： A61K9/70 , A61K31/485 , A61K47/12 , A61K47/32 , A61K47/34 , A61P25/04 , A61P25/30
CPC分类号： A61K9/7061 , A61K31/485
摘要： The invention relates to a transdermal therapeutic system (TTS) comprising a support layer which is impermeable to the active ingredient, a self-adhesive matrix consisting of a cationic base polymer and a detachable protective film on the side facing the skin. As active ingredient the matrix contains organic acid addition salts of morphine alkaloids on the basis of a water-soluble polyaminomethacrylate salt containing fatty acids. The invention is characterized in that a sparingly water-soluble copolymer of acrylic and methacrylic acid esters with a comparatively low quaternary content of ammonium groups which form a salt with inorganic acids is admixed to the cationic base polymer.
摘要翻译：的透皮治疗系统（TTS），其包括一个活性物质不可渗透的背层，阳离子基础聚合物和所述面向皮肤侧上的可取下的保护片的自粘性基质，所述基于脂肪酸的含酸含吗啡生物碱的作为活性物质的有机酸加成盐基质，水溶性Polyaminomethacrylatsalzes是其特征在于，所述阳离子基础聚合物是丙烯酸和甲基丙烯酸酯的具有相对小的内容的有限的水溶性共聚物，其中加入了形成与无机酸盐的季铵基团。

6. 发明申请

WO2010091822A8 N-HYDROXYLATED AMIDINE-, GUANIDINE- AND/OR AMINOHYDRAZONE-TYPE PRODRUGS FOR APPLICATION ON THE SKIN 审中-公开
标题翻译：前体药物类型N-羟基脒，胍和/或AMINOHYDRAZONE通过皮肤施用
公开(公告)号：WO2010091822A8
公开(公告)日：2011-08-11
申请号：PCT/EP2010000715
申请日：2010-02-05
申请人： LOHMANN THERAPIE SYST LTS , MATUSCH RUDOLF , HOFFMANN HANS-RAINER , ASMUSSEN BODO , KOCH ANDREAS
发明人： MATUSCH RUDOLF , HOFFMANN HANS-RAINER , ASMUSSEN BODO , KOCH ANDREAS
IPC分类号： A61K9/00 , A61K9/70 , A61K31/155 , A61K31/4245 , A61K47/48
CPC分类号： A61K9/0014
摘要： The invention relates to N-hydroxylated amidines, guanidines and aminohydrazones for application on the skin. In particular, the invention relates to transdermal therapeutic systems, containing N-hydroxylated amidines, guanidines and aminohydrazones as a prodrug, and to methods for producing and using such systems.
摘要翻译：本发明涉及N-羟基化脒，胍，和Aminohydrazone用于皮肤上的应用程序。特别地，本发明涉及一种透皮治疗系统使用N-羟基脒，胍，和Aminohydrazone包含作为前药，以及制造和使用这种系统的方法。

7. 发明申请

WO2011101227A3 DEVICE AND METHOD FOR OBTAINING, ESPECIALLY IN SITU, A CARBONACEOUS SUBSTANCE FROM AN UNDERGROUND DEPOSIT 审中-公开
标题翻译：设备和方法进行生产，特别是在原位生成，含碳物质从地下水库
公开(公告)号：WO2011101227A3
公开(公告)日：2012-04-05
申请号：PCT/EP2011051279
申请日：2011-01-31
申请人： SIEMENS AG , HUBER NORBERT , DIEHL DIRK , KOCH ANDREAS , KOOLMAN MICHAEL , TORLAK MURIS , WACKER BERND
发明人： HUBER NORBERT , DIEHL DIRK , KOCH ANDREAS , KOOLMAN MICHAEL , TORLAK MURIS , WACKER BERND
IPC分类号： E21B43/24 , E21B43/30
CPC分类号： E21B43/2401 , E21B17/18 , E21B34/06 , E21B43/305
摘要： The invention relates to a device and a method for extracting a carbonaceous substance, especially bitumen or extra-heavy oil, from a reservoir (6). Thermal energy can be supplied to the reservoir (6) to reduce the viscosity of the substance. For this purpose, at least one conductor loop (10, 11) is provided as an electric/electromagnetic heater to be inductively supplied with power, a conductor (10) of the conductor loop (10, 11) being surrounded by a liquid-carrying conduit (12) in at least one section and said liquid conduit (12) being perforated so that when liquid is supplied said liquid penetrates into the reservoir (6) from the liquid-carrying conduit (12) via a perforation (21).
摘要翻译：本发明涉及一种装置和促进烃类物质的方法，尤其是沥青或重油，从储存器（6），其中所述贮存器（6）可在与热能作用以降低物质的粘度，向其中至少一个导体环（10 ，11）被设置用于导体环（10的感应电流的流动作为电气/电磁加热，其特征在于，导体（10），11）中至少一个部分所包围（流体引导件12）和流体导向装置（12）的穿孔，使得在通过在所述储存器（6）的液体导向件（12）的穿孔（21）供给的液体的液体渗入。

8. 发明申请

WO2010091822A3 N-HYDROXYLATED AMIDINE-, GUANIDINE- AND/OR AMINOHYDRAZONE-TYPE PRODRUGS FOR APPLICATION ON THE SKIN 审中-公开
标题翻译：用于皮肤应用的N-羟基脒，胍和/或氨基腙类
公开(公告)号：WO2010091822A3
公开(公告)日：2011-10-13
申请号：PCT/EP2010000715
申请日：2010-02-05
申请人： LOHMANN THERAPIE SYST LTS , MATUSCH RUDOLF , HOFFMANN HANS-RAINER , ASMUSSEN BODO , KOCH ANDREAS
发明人： MATUSCH RUDOLF , HOFFMANN HANS-RAINER , ASMUSSEN BODO , KOCH ANDREAS
IPC分类号： A61K9/00 , A61K9/70 , A61K31/155 , A61K31/4245 , A61K47/48
CPC分类号： A61K9/0014
摘要： The invention relates to N-hydroxylated amidines, guanidines and aminohydrazones for application on the skin. In particular, the invention relates to transdermal therapeutic systems, containing N-hydroxylated amidines, guanidines and aminohydrazones as a prodrug, and to methods for producing and using such systems.
摘要翻译：本发明涉及用于通过皮肤给药的N-羟基化脒，胍和氨基腙。具体而言，本发明涉及含有N-羟基化脒，胍和氨基腙作为前药的透皮治疗系统，以及制造和使用此类系统的方法。

9. 发明申请

WO2008141630A3 LAMP SOCKET FOR AN ELECTRIC LAMP 审中-公开
标题翻译： LAMP基地电灯
公开(公告)号：WO2008141630A3
公开(公告)日：2009-04-30
申请号：PCT/DE2008000859
申请日：2008-05-21
申请人： OSRAM GMBH , SCHEMPP & DECKER PRAEZ STEILE , HUBERT STUEKEN GMBH & CO KG , UNIV ERLANGEN NUERNBERG VERTRE , HELBIG PETER , VOGEL ALEXANDER , KOCH ANDREAS , QUADFASEL KARL-HEINZ , EHRENSTEIN GOTTFRIED W , AMESODER SIMON , SZAMEITAT MIKE , SCHOLZ MATTHIAS
发明人： HELBIG PETER , VOGEL ALEXANDER , KOCH ANDREAS , QUADFASEL KARL-HEINZ , EHRENSTEIN GOTTFRIED W , AMESODER SIMON , SZAMEITAT MIKE , SCHOLZ MATTHIAS
IPC分类号： H01K1/46 , H01J5/54
CPC分类号： H01K1/46 , B29C45/1657 , B29C45/1671 , F21S41/19 , H01J5/54 , H01K1/42
摘要： A lamp socket for an electric lamp, in particular, for a motor vehicle headlamp with a plastic socket part is disclosed, with a first section made from a higher meting plastic in a region adjacent to the lamp bulb and a second section made from a lower melting plastic in a region of mechanical stress. Savings can thus be made in cost-intensive higher melting plastics whilst at the same time guaranteeing a longer service life in the region of mechanical stress.
摘要翻译：它是用塑料材料用于机动车辆头灯，设置在基座部，灯座用于电灯，特别是相邻的较高熔点的塑料在到灯容器中并在机械应力的区域由较低熔点的塑料的第二部分的区域中的第一部分。以这种方式昂贵较高熔点的塑料可以被保存，而在同一时间更长的使用寿命可以被固定在机械应力的区域中。

10. 发明申请

WO0071125A3 PHARMACEUTICAL PREPARATION CONTAINING THE ACTIVE SUBSTANCE DIAMORPHINE AND ITS UTILIZATION IN A METHOD FOR TREATING OPIATE ADDICTION 审中-公开
标题翻译：与ACTIVE海洛因药物制备及其用途的方法，阿片类药物治疗网瘾
公开(公告)号：WO0071125A3
公开(公告)日：2001-03-15
申请号：PCT/EP0004458
申请日：2000-05-17
申请人： LOHMANN THERAPIE SYST LTS , MATUSCH RUDOLF , ADAM BERND , KOCH ANDREAS , HOFFMANN HANS RAINER , ASMUSSEN BODO
发明人： MATUSCH RUDOLF , ADAM BERND , KOCH ANDREAS , HOFFMANN HANS-RAINER , ASMUSSEN BODO
IPC分类号： A61K9/70 , A61K31/485 , A61K47/06 , A61K47/10 , A61K47/12 , A61K47/22 , A61K47/32 , A61K47/34 , A61P25/04 , A61P25/36
CPC分类号： A61K9/7053 , A61K9/7061 , A61K31/485
摘要： The invention relates to pharmaceutical preparations that are used in a method for treating opiate addiction or opiate dependence, especially heroin dependence. The active substance used is preferably diamorphine and/or one of the pharmaceutically acceptable acid addition salts thereof. The invention also relates to a method for treating opiate dependence.
摘要翻译：本发明涉及一种用于在一个方法中使用阿片类药物成瘾或阿片成瘾，特别是Heroinabhäbhängigkeit的治疗的药物制剂。使用的活性成分，优选为二乙酰吗啡和/或它的药学上可接受的酸加成盐中的一种。阿片类依赖的治疗的方法也被描述。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式